300030 阳普医疗
已收盘 01-07 15:00:00
资讯
新帖
简况
阳普医疗（300030）披露关于持股5%以上股东一致行动人股份解除冻结的公告，11月24日股价上涨3.27%
证券之星 · 2025-11-24
阳普医疗（300030）披露关于持股5%以上股东一致行动人股份解除冻结的公告，11月24日股价上涨3.27%
阳普医疗：截至2025年9月30日股东数量为28,504户
证券之星 · 2025-11-24
阳普医疗：截至2025年9月30日股东数量为28,504户
阳普医疗（300030）披露召开2025年第一次临时股东会通知，11月12日股价上涨4.13%
证券之星 · 2025-11-12
阳普医疗（300030）披露召开2025年第一次临时股东会通知，11月12日股价上涨4.13%
阳普医疗：公司业务不涉及脑机接口领域
证券之星 · 2025-11-12
阳普医疗：公司业务不涉及脑机接口领域
阳普医疗（300030）2025年三季报简析：净利润同比增长156.55%，盈利能力上升
证券之星 · 2025-10-29
阳普医疗（300030）2025年三季报简析：净利润同比增长156.55%，盈利能力上升
阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%
智通财经 · 2025-10-27
阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%
阳普医疗新注册《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》等2个项目的软件著作权
证券之星 · 2025-08-31
阳普医疗新注册《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》等2个项目的软件著作权
8月27日阳普医疗跌5.74%，华夏智胜先锋股票C基金重仓该股
证券之星 · 2025-08-27
8月27日阳普医疗跌5.74%，华夏智胜先锋股票C基金重仓该股
8月18日阳普医疗涨5.59%，华夏智胜先锋股票C基金重仓该股
证券之星 · 2025-08-18
8月18日阳普医疗涨5.59%，华夏智胜先锋股票C基金重仓该股
阳普医疗（300030）2025年中报简析：净利润增389.4%，盈利能力上升
证券之星 · 2025-08-16
阳普医疗（300030）2025年中报简析：净利润增389.4%，盈利能力上升
阳普医疗最新公告：上半年净利润1526.66万元 同比扭亏
证券之星 · 2025-08-14
阳普医疗最新公告：上半年净利润1526.66万元 同比扭亏
8月14日阳普医疗跌5.86%，华夏智胜先锋股票C基金重仓该股
证券之星 · 2025-08-14
8月14日阳普医疗跌5.86%，华夏智胜先锋股票C基金重仓该股
病毒检测概念盘中拉升，阳普医疗涨4.80%
市场透视 · 2025-08-12
病毒检测概念盘中拉升，阳普医疗涨4.80%
阳普医疗：2025年是公司改善业绩、实现战略突破的关键年份
证券之星 · 2025-08-12
阳普医疗：2025年是公司改善业绩、实现战略突破的关键年份
阳普医疗新注册《阳普医疗全自动血栓弹力图仪温度控制软件V1》等3个项目的软件著作权
证券之星 · 2025-08-11
阳普医疗新注册《阳普医疗全自动血栓弹力图仪温度控制软件V1》等3个项目的软件著作权
8月7日阳普医疗涨8.53%，华夏智胜先锋股票C基金重仓该股
证券之星 · 2025-08-07
8月7日阳普医疗涨8.53%，华夏智胜先锋股票C基金重仓该股
阳普医疗：邓冠华已不再行使经营管理决策权
证券之星 · 2025-07-16
阳普医疗：邓冠华已不再行使经营管理决策权
体外诊断概念盘中拉升，阳普医疗涨16.90%
市场透视 · 2025-07-07
体外诊断概念盘中拉升，阳普医疗涨16.90%
阳普医疗：关于高级管理人员辞职的公告
新浪财经-鹰眼工作室 · 2025-02-28
阳普医疗：关于高级管理人员辞职的公告
阳普医疗最新公告：副总经理徐立新因个人原因辞职
证券之星 · 2025-02-28
阳普医疗最新公告：副总经理徐立新因个人原因辞职
加载更多
公司概况
公司名称：
阳普医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2009-12-25
主营业务：
阳普医疗科技股份有限公司的主营业务是精准医疗、智慧医疗和检验服务。公司的主要产品是智慧实验室产品、IVD(体外诊断)产品、检验服务、信息化产品。公司是从事标本分析前变异控制研究近三十年的高新技术企业，深耕成为国内静脉标本采集领域龙头，在全球行业排名中位列前茅。
发行价格：
25.00
{"stockData":{"symbol":"300030","market":"SZ","secType":"STK","nameCN":"阳普医疗","latestPrice":7.62,"timestamp":1767769422000,"preClose":7.88,"halted":0,"volume":9535632,"delay":0,"changeRate":-0.033,"floatShares":272000000,"shares":309000000,"eps":-0.1661,"marketStatus":"已收盘","change":-0.26,"latestTime":"01-07 15:00:00","open":7.88,"high":7.9,"low":7.6,"amount":73466100,"amplitude":0.0381,"askPrice":7.63,"askSize":1782,"bidPrice":7.62,"bidSize":167,"shortable":0,"etf":0,"ttmEps":-0.1661,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767835800000},"marketStatusCode":5,"adr":0,"adjPreClose":7.88,"symbolType":"stock","openAndCloseTimeList":[[1767749400000,1767756600000],[1767762000000,1767769200000]],"highLimit":8.67,"lowLimit":7.09,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":309187315,"isCdr":false,"pbRate":3.86,"roa":"--","roe":"3.89%","epsLYR":-0.38,"committee":-0.110076,"marketValue":2356000000,"turnoverRate":0.035,"status":1,"floatMarketCap":2074000000},"requestUrl":"/m/hq/s/300030","defaultTab":"news","newsList":[{"id":"2585446498","title":"阳普医疗（300030）披露关于持股5%以上股东一致行动人股份解除冻结的公告，11月24日股价上涨3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446498","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585446498?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:30","pubTimestamp":1763994626,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，阳普医疗报收于7.9元，较前一交易日上涨3.27%，最新总市值为24.43亿元。阳普医疗科技股份有限公司于近日发布公告，公司持股5%以上股东赵吉庆先生所持有的5,600,000股股份已于2025年11月20日解除冻结，该部分股份占其持股总数的36.60%，占公司总股本的1.81%，原冻结法院为江苏省南京市中级人民法院。本次解除冻结后，赵吉庆及其一致行动人邓冠华合计持股64,494,555股，占公司总股本20.86%，累计被冻结股份数量为0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400036023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030","BK0146","BK0028","BK0251"],"gpt_icon":0},{"id":"2585590544","title":"阳普医疗：截至2025年9月30日股东数量为28,504户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585590544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585590544?lang=zh_cn&edition=full","pubTime":"2025-11-24 15:39","pubTimestamp":1763969972,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)11月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问10月31日的股东人数多少，谢谢阳普医疗回复：尊敬的投资者，您好！公司按照相关规定以及为保证所有投资者平等获悉公司信息，公司在定期报告中面向所有投资者披露了截至报告期末的股东人数。截至2025年9月30日（第三季度期末）股东数量为28,504户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400013303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0146","300030","BK0028"],"gpt_icon":0},{"id":"2582219483","title":"阳普医疗（300030）披露召开2025年第一次临时股东会通知，11月12日股价上涨4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582219483","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582219483?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:32","pubTimestamp":1762939931,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，阳普医疗报收于8.58元，较前一交易日上涨4.13%，最新总市值为26.53亿元。该股当日开盘8.24元，最高8.63元，最低8.22元，成交额达2.32亿元，换手率为10.04%。公司近日发布公告称，阳普医疗科技股份有限公司将于2025年11月27日召开2025年第一次临时股东会，会议由董事会召集，现场会议时间为当日15:30，网络投票时间为9:15至15:00。股权登记日为2025年11月21日。登记时间为2025年11月26日，股东可通过现场或通讯方式登记参会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200028486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030","BK0146","BK0251","BK0028"],"gpt_icon":0},{"id":"2582326737","title":"阳普医疗：公司业务不涉及脑机接口领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2582326737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582326737?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:54","pubTimestamp":1762937649,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问贵公司在脑机接口领域有哪些具体布局，在整个行业大约处于何市场地位？目前是否已经产生收入？阳普医疗回复：尊敬的投资者，您好！公司业务不涉及脑机接口领域，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200026275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300030","BK0146","BK0028"],"gpt_icon":0},{"id":"2579916345","title":"阳普医疗（300030）2025年三季报简析：净利润同比增长156.55%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579916345","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579916345?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:37","pubTimestamp":1761691027,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期阳普医疗发布2025年三季报。截至本报告期末，公司营业总收入3.49亿元，同比下降17.14%，归母净利润2404.41万元，同比上升156.55%。按单季度数据看，第三季度营业总收入1.18亿元，同比下降7.82%，第三季度归母净利润877.75万元，同比上升123.57%。本报告期阳普医疗盈利能力上升，毛利率同比增幅5.59%，净利率同比增幅163.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900010426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030"],"gpt_icon":0},{"id":"2578615579","title":"阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578615579","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578615579?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:57","pubTimestamp":1761555444,"startTime":"0","endTime":"0","summary":"智通财经APP讯，阳普医疗(300030.SZ)发布2025年三季度报告，该公司前三季度营业收入为3.49亿元，同比减少17.14%。归属于上市公司股东的净利润为2404.41万元，同比增长156.55%。归属于上市公司股东的扣除非经常性损益的净利润为3035.77万元，同比增长325.04%。基本每股收益为0.08元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300030"],"gpt_icon":0},{"id":"2563884365","title":"阳普医疗新注册《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2563884365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563884365?lang=zh_cn&edition=full","pubTime":"2025-08-31 01:46","pubTimestamp":1756575973,"startTime":"0","endTime":"0","summary":"证券之星消息，近日阳普医疗新注册了2个项目的软件著作权，包括《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》、《阳普医疗全自动血栓弹力图仪主调度软件V1》等。今年以来阳普医疗新注册软件著作权7个。通过天眼查大数据分析，阳普医疗科技股份有限公司共对外投资了17家企业，参与招投标项目384次；财产线索方面有商标信息178条，专利信息183条，著作权信息29条；此外企业还拥有行政许可135个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100000169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300030","BK0146","BK0251"],"gpt_icon":0},{"id":"2562715555","title":"8月27日阳普医疗跌5.74%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562715555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562715555?lang=zh_cn&edition=full","pubTime":"2025-08-27 16:28","pubTimestamp":1756283335,"startTime":"0","endTime":"0","summary":"证券之星消息，8月27日阳普医疗跌5.74%，收盘报8.21元，换手率8.52%，成交量23.18万手，成交额1.96亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4992，较上一交易日上涨0.33%，近一年上涨58.83%。该公募基金现任基金经理为孙蒙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700033815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300030","BK0146"],"gpt_icon":0},{"id":"2560977089","title":"8月18日阳普医疗涨5.59%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2560977089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560977089?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:27","pubTimestamp":1755505656,"startTime":"0","endTime":"0","summary":"证券之星消息，8月18日阳普医疗涨5.59%，收盘报9.07元，换手率13.47%，成交量36.66万手，成交额3.34亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4395，较上一交易日上涨1.24%，近一年上涨48.71%。该公募基金现任基金经理为孙蒙。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800021695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","300030","BK0251"],"gpt_icon":0},{"id":"2559894906","title":"阳普医疗（300030）2025年中报简析：净利润增389.4%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2559894906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559894906?lang=zh_cn&edition=full","pubTime":"2025-08-16 06:06","pubTimestamp":1755295588,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期阳普医疗发布2025年中报。截至本报告期末，公司营业总收入2.31亿元，同比下降21.22%，归母净利润1526.66万元，同比上升389.4%。按单季度数据看，第二季度营业总收入1.15亿元，同比下降24.07%，第二季度归母净利润745.81万元，同比上升457.8%。本报告期阳普医疗盈利能力上升，毛利率同比增幅3.34%，净利率同比增幅534.76%。短期借款变动幅度为-30.39%,原因:降低贷款规模，自有资金偿还银行借款。财务费用变动幅度为-62.4%,原因:报告期利息费用减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081600004388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030"],"gpt_icon":0},{"id":"2559585956","title":"阳普医疗最新公告：上半年净利润1526.66万元 同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2559585956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559585956?lang=zh_cn&edition=full","pubTime":"2025-08-14 18:10","pubTimestamp":1755166216,"startTime":"0","endTime":"0","summary":"阳普医疗(300030.SZ)发布2025年半年度报告，公司实现营业收入2.31亿元，同比下降21.22%；净利润1526.66万元，同比扭亏。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400035910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030"],"gpt_icon":0},{"id":"2559300889","title":"8月14日阳普医疗跌5.86%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2559300889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559300889?lang=zh_cn&edition=full","pubTime":"2025-08-14 16:18","pubTimestamp":1755159518,"startTime":"0","endTime":"0","summary":"证券之星消息，8月14日阳普医疗跌5.86%，收盘报8.35元，换手率11.34%，成交量29.48万手，成交额2.51亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4421，较上一交易日上涨0.82%，近一年上涨48.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400029958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300030","BK0028","BK0146"],"gpt_icon":0},{"id":"2558519692","title":"病毒检测概念盘中拉升，阳普医疗涨4.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558519692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558519692?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:51","pubTimestamp":1754963496,"startTime":"0","endTime":"0","summary":"08月12日，病毒检测概念盘中拉升，截至09点51分，病毒检测概念整体指数上涨0.61%，报1135.980点。从个股上来看，该概念的成分股中，阳普医疗涨4.80%，乐普医疗、复星医药、硕世生物涨幅居前。从资金上来看，截止发稿，病毒检测概念主力净流入为-3.35亿，其中乐普医疗受到资金热捧，主力净流入3970.50万；拉长时间线来看，该板块近20日主力资金净流入-37.98亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095136a482f593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095136a482f593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399","BK0146","BK0028","BK0239","BK0251","300030"],"gpt_icon":0},{"id":"2558269182","title":"阳普医疗：2025年是公司改善业绩、实现战略突破的关键年份","url":"https://stock-news.laohu8.com/highlight/detail?id=2558269182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558269182?lang=zh_cn&edition=full","pubTime":"2025-08-12 08:51","pubTimestamp":1754959878,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗08月11日在投资者关系平台上答复投资者关心的问题。主营真空采血系统，说是国内龙头公司，可是连年亏损，还能依靠主营生存吗阳普医疗回复：尊敬的投资者，您好！2025年是公司改善业绩、实现战略突破的关键年份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081200007506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0251","300030"],"gpt_icon":0},{"id":"2558684565","title":"阳普医疗新注册《阳普医疗全自动血栓弹力图仪温度控制软件V1》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684565","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558684565?lang=zh_cn&edition=full","pubTime":"2025-08-11 01:29","pubTimestamp":1754846948,"startTime":"0","endTime":"0","summary":"证券之星消息，近日阳普医疗新注册了3个项目的软件著作权，包括《阳普医疗全自动血栓弹力图仪温度控制软件V1》、《阳普医疗全自动血栓弹力图仪悬丝控制软件V1》、《阳普医疗全自动血栓弹力图仪样本检测控制软件V1》等。今年以来阳普医疗新注册软件著作权5个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100000361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300030","BK0146","BK0028"],"gpt_icon":0},{"id":"2557537110","title":"8月7日阳普医疗涨8.53%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2557537110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557537110?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:15","pubTimestamp":1754554503,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日阳普医疗涨8.53%创60日新高，收盘报9.29元，换手率24.67%，成交量64.11万手，成交额5.95亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4142，较上一交易日上涨0.56%，近一年上涨45.93%。该公募基金现任基金经理为孙蒙。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700025895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300030","BK0146","BK0028"],"gpt_icon":0},{"id":"2551457541","title":"阳普医疗：邓冠华已不再行使经营管理决策权","url":"https://stock-news.laohu8.com/highlight/detail?id=2551457541","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551457541?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:36","pubTimestamp":1752654975,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问邓冠华作为公司第一大股东，是否已放弃参与公司经营管理的权力？阳普医疗回复：尊敬的投资者，您好！通过协议约定及职务调整，邓冠华先生已不再行使经营管理决策权。公司运营由控股股东委派的管理团队负责，确保经营稳定。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600026071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","300030","BK0251"],"gpt_icon":0},{"id":"2549308265","title":"体外诊断概念盘中拉升，阳普医疗涨16.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549308265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549308265?lang=zh_cn&edition=full","pubTime":"2025-07-07 09:49","pubTimestamp":1751852985,"startTime":"0","endTime":"0","summary":"07月07日，体外诊断概念盘中拉升，截至09点49分，体外诊断概念整体指数上涨1.06%，报1113.940点。从个股上来看，该概念的成分股中，阳普医疗涨16.90%，塞力医疗、迪瑞医疗2只股涨幅超过5%。从资金上来看，截止发稿，体外诊断概念概念主力净流入为-9382.70万，其中浩欧博受到资金热捧，主力净流入1194.74万；拉长时间线来看，该板块近20日主力资金净流入-30.14亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094945979c7355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094945979c7355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","300030","BK0251","BK0239","BK0028","688656"],"gpt_icon":0},{"id":"2514706349","title":"阳普医疗：关于高级管理人员辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2514706349","media":"新浪财经-鹰眼工作室","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514706349?lang=zh_cn&edition=full","pubTime":"2025-02-28 18:00","pubTimestamp":1740736800,"startTime":"0","endTime":"0","summary":"阳普医疗科技股份有限公司关于高级管理人员辞职的公告阳普医疗科技股份有限公司董事会于近日收到公司副总经理徐立新先生递交的辞职报告，其因个人原因辞去公司副总经理职位，辞任后徐立新先生不再担任公司任何职务。根据相关规定，徐立新先生的辞职报告自送达公司董事会之日起生效。徐立新先生在担任公司副总经理期间勤勉尽责，公司及董事会对徐立新先生任职期间为公司所做的贡献表示衷心感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-02-28/doc-inemzuif5476378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0028","BK0251","300030"],"gpt_icon":0},{"id":"2514162346","title":"阳普医疗最新公告：副总经理徐立新因个人原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2514162346","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514162346?lang=zh_cn&edition=full","pubTime":"2025-02-28 17:39","pubTimestamp":1740735572,"startTime":"0","endTime":"0","summary":"阳普医疗(300030.SZ)公告称，公司董事会近日收到副总经理徐立新递交的辞职报告，徐立新因个人原因辞去公司副总经理职位，原定任期为2023年6月21日至2026年6月20日。辞任后徐立新不再担任公司任何职务，但将继续担任公司全资子公司吉迪思诊断有限公司执行董事兼总经理职务至2025年3月31日止。徐立新持有公司6,000股股票，其离任后将继续遵守相关股份管理规定。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800031828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0251","300030"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767770256196,"stockEarnings":[{"period":"1week","weight":0.0765},{"period":"1month","weight":0.0013},{"period":"3month","weight":0.0274},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.4812},{"period":"ytd","weight":0.0707}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"阳普医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"28504人(较上一季度增加16.74%)","perCapita":"9550股","listingDate":"2009-12-25","address":"广东省珠海市香洲区横琴新区环岛东路3000号横琴国际商务中心801-8017室","registeredCapital":"30918万元","survey":" 阳普医疗科技股份有限公司的主营业务是精准医疗、智慧医疗和检验服务。公司的主要产品是智慧实验室产品、IVD(体外诊断)产品、检验服务、信息化产品。公司是从事标本分析前变异控制研究近三十年的高新技术企业，深耕成为国内静脉标本采集领域龙头，在全球行业排名中位列前茅。","listedPrice":25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阳普医疗(300030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阳普医疗(300030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阳普医疗,300030,阳普医疗股票,阳普医疗股票老虎,阳普医疗股票老虎国际,阳普医疗行情,阳普医疗股票行情,阳普医疗股价,阳普医疗股市,阳普医疗股票价格,阳普医疗股票交易,阳普医疗股票购买,阳普医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阳普医疗(300030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阳普医疗(300030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}